A Randomized, Open Labeled, Multiple Dose, 2-Sequence, 2-Period Cross-over Phase 1 Study to Evaluate the Drug-Drug Interaction of PK101-001 and PK101-002 in Healthy Volunteers.
To evaluate the drug-drug interaction of PK101-001 and PK101-002 in healthy volunteers.
100 项与 PK-101-002 相关的临床结果
100 项与 PK-101-002 相关的转化医学
100 项与 PK-101-002 相关的专利(医药)
100 项与 PK-101-002 相关的药物交易